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Cardiac rehabilitation improves quality of life and walking
tolerance in elderly patients with heart failure
Synopsis
Commentary
Summary of: Austin J, Williams R, Ross L, Mosely L and
Hutchison S (2005): Randomised controlled trial of cardiac
rehabilitation in elderly patients with heart failure. The
European Journal of Heart Failure 7: 411–417. (Prepared by
Mark Elkins, CAP Editor.)
Question For patients over 60 years of age with heart failure,
does cardiac rehabilitation improve outcomes over standard
care at a heart failure clinic? Design Randomised controlled
trial with concealed allocation and blinded assessors. Setting
Participants were recruited from the acute medical unit and
outpatient clinics of a UK hospital and surrounding general
practices. Patients Patients over 60 years of age with New
York Heart Association (NYHA) class II or III heart failure
and left ventricular systolic dysfunction (ejection fraction ≤
40%). Exclusion criteria included diastolic dysfunction and
significant co-morbidities. Thirty-five eligible patients
refused to participate. The remaining 200 were randomised to
cardiac rehabilitation (n = 100) or standard care (n = 100).
Interventions Patients in both groups received outpatient
monitoring of their clinical status every eight weeks for 24
weeks, an explanation of heart failure, advice regarding diet
and self-monitoring for fluid overload, and a record of their
medications, test results, and appointments. During the first
eight weeks, the cardiac rehabilitation group also attended
twice weekly classes for aerobic and low resistance strength
training, and educational input on medication, diet and
exercise. For the latter 16 weeks, this group attended
community-based exercise classes weekly. This group also
received transport to the classes if necessary, encouragement
to exercise an additional three times per week at home, and
written materials. Outcomes NYHA classification and the
Minnesota living with heart failure (MLHF) questionnaire
were assessed at baseline, eight and 24 weeks. The six minute
walk test (6MWT) and the EuroQol questionnaire were
assessed at baseline and 24 weeks. Hospital admissions due to
heart disease were also recorded. Results: Change in NYHA
classification was significantly better in the cardiac
rehabilitation group than the control group at eight weeks
(Mann-Whitney test, p = 0.001) and at 24 weeks (p < 0.001).
The cardiac rehabilitation group was significantly better than
the control group on the MLHF score at 8 weeks (13 points,
95% CI 7 to 19) and at 24 weeks (14 points, 95% CI 8 to 20).
The cardiac rehabilitation group was also significantly better
than the control group on the 6MWT (68 m, 95% CI 33 to
102) and the EuroQol score (12 points, 95% CI 7 to 17).
Hospital admissions (p < 0.01) and days in hospital (p <
0.001) were also significantly fewer in the cardiac
rehabilitation group. Conclusion For patients over 60 years
with heart failure cardiac rehabilitation provides important
benefits over outpatient clinic care.
The provision of exercise and rehabilitative therapy is
recommended in international guidelines for the management
of coronary heart disease. Whilst there is good physiological
evidence supporting exercise as an effective intervention for
patients with chronic heart failure, there is little in the
literature describing large-scale delivery of a rehabilitation
program. Also, a systematic review of exercise training for
heart failure found a lack of studies in the elderly (Rees et al
2004). This paper describes the results of a low-tech exercise
program in a large group of elderly patients (over 60 years)
with heart failure (n = 200). The results are impressive,
reporting significant improvements in the six minute walking
test (6MWT) distance and quality of life. The authors
underplay the dramatic reduction in the total number of
admissions and the hospital days after rehabilitation.
From a clinical perspective several interesting points emerge.
The authors screened 493 potential patients but excluded 293.
The majority were excluded because of co-morbidities (52%),
and a smaller number refused to participate. There were
changes to the medication in both groups during the course of
the program. These were evenly distributed except for the
prescription of β-blockers, which was enhanced in the
experimental group. This discrepancy is potentially a
confounding variable making it difficult for the reader to
ascertain the relative contribution to the change in 6MWT
distance i.e., the exercise training regime or the change in
medication. Furthermore we are unable to identify where the
changes in exercise tolerance occurred – during the initial
hospital phase or later in the community? Whilst not directly
comparable, the minimum clinically important difference for
the 6MWT for a COPD population has been described (54 m)
(Redelmeier et al 1997). The difference between the groups,
whilst not identified, would be in the region of 45 m. The
proportion of patients exceeding this limit would define the
responders from non-responders. Despite these issues this
paper makes a welcome and valuable contribution to the care
of patients with heart failure.
Sally Singh
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